翔宇醫療(688626.SH):已有10餘項運用國內非侵入型腦機電或神經肌電類技術及產品
格隆匯3月20日丨翔宇醫療(688626.SH)在投資者互動平台表示,公司早期就有腦機接口領域的研發和佈局,已完成與天津大學、西安交通大學等聯合承擔的“生-機智能交互與生機電一體化機器人技術”國家重點專項。目前公司已有10餘項運用國內非侵入型腦機電或神經肌電類技術及產品,比如下肢反饋康復訓練系統、肌電生物反饋等,以及部分正在辦理註冊中的產品,實現了腦電的採集、評估及團體的訓練等,前者還應用到高校“腦控”和“腦機接口”的研究,通過捕捉癱瘓患者的運動意念,將運動意念與機器結合,激發神經重塑,幫助癱瘓患者重新站立。公司還在腦電採集、新生兒腦功能監測等方面申報了眾多專利,且已有專利獲得授權,將會推出新生兒腦功能監測、微電流及團體腦功能訓練相關產品,針對新生兒腦監測、大腦注意力問題、焦慮、抑鬱及情緒控制等問題,形成腦功能診療一體的解決方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.